Home Cart 0 Sign in  
X

[ CAS No. 36745-93-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 36745-93-4
Chemical Structure| 36745-93-4
Chemical Structure| 36745-93-4
Structure of 36745-93-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 36745-93-4 ]

Related Doc. of [ 36745-93-4 ]

Alternatived Products of [ 36745-93-4 ]

Product Details of [ 36745-93-4 ]

CAS No. :36745-93-4 MDL No. :MFCD22572319
Formula : C7H6Cl2N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :LJPTXNUMWNYLDV-UHFFFAOYSA-N
M.W : 221.04 Pubchem ID :57531614
Synonyms :

Calculated chemistry of [ 36745-93-4 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.29
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.3
TPSA : 52.08 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.96 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.31
Log Po/w (XLOGP3) : 2.38
Log Po/w (WLOGP) : 1.88
Log Po/w (MLOGP) : 1.07
Log Po/w (SILICOS-IT) : 2.48
Consensus Log Po/w : 2.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.92
Solubility : 0.266 mg/ml ; 0.0012 mol/l
Class : Soluble
Log S (Ali) : -3.11
Solubility : 0.17 mg/ml ; 0.000768 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.36
Solubility : 0.0974 mg/ml ; 0.000441 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.95

Safety of [ 36745-93-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 36745-93-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 36745-93-4 ]
  • Downstream synthetic route of [ 36745-93-4 ]

[ 36745-93-4 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 869891-41-8 ]
  • [ 36745-93-4 ]
YieldReaction ConditionsOperation in experiment
78% at 105℃; for 6 h; Preparation 1Methyl 2,4-dichloro-6-methylpyrimidine-5-carboxylate To a suspension of methyl 6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (1 g, 5.43 mmol) in POCl3 (10 mL) was added 10 drops of N,N-dimethylaniline. The reaction mixture was heated at 105° C. for 6 h until it became a clear solution. It was then cooled, concentrated under reduced pressure, poured over ice, and extracted with EtOAc. The organic extract was washed with water and brine, dried and concentrated under reduced pressure to give the title compound as greenish-yellow solid (940 mg, 78percent). [M+H] calc'd for C7H6Cl2N2O2, 222. found, 221, 223.
70.2% at 110℃; for 2 h; Synthesis of compound 1.5. A solution of 1.4 (12.1 g, 0.06576 mol, 1.00 equiv) in phosphorusoxychloride (120ml) was heated at 110 °C for 2 hrs. After completion, reaction mixture was concentrated under reduced pressure and residue was quenched in ice. The crude product was extracted twice with ethyl acetate. The organic layers were dried over sodium sulfate and concentrated under reduced pressure to afford crude material which was purified by flash column chromatography This resulted in pure compound 1.5 (10.2g, 70.20percent>). MS (ES): m/z 222.8 [M+H]+
59% at 95℃; for 3 h; c)
Synthesis of 2,4-dichloro-6-methyl-pyrimidine-5-carboxylic acid methyl ester
4-Methyl-2,6-dioxo-3H-pyrimidine-5-carboxylic acid methyl ester (0.64 g, 3.48 mmol) is dissolved in phosphoryl chloride (6.5 ml) and to it is added tributylamine (1.75 ml).
The resulting mixture is heated at 95° C. for 3 h.
Excess phosphoryl chloride is distilled of and ice-water is added to the reaction mixture and extracted with EtOAc (3*30 ml).
The combined organic layers are washed with water (30 ml), brine (30 ml), evaporated to dryness to get the crude product, which is purified by column chromatography (silica gel, 5percent EtOAc/hexane) affording 2,4-dichloro-6-methyl-pyrimidine-5-carboxylic acid methyl ester (0.45 g, 2.04 mmol, 59percent).
59% at 95℃; for 3 h; 4-Methyl-2,6-dioxo-3H-pyrimidine-5-carboxylic acid methyl ester (0.64 g, 3.48 mmol) is dissolved in phosphoryl chloride (6.5 ml) and to it is added tributylamine (1.75 ml). The resulting mixture is heated at 95 °C for 3 h. Excess phosphoryl chloride is distilled of and ice-water is added to the reaction mixture and extracted with EtOAc (3 x 30 ml). The combined organic layers are washed with water (30 ml), brine (30ml), evaporated to dryness to get the crude product, which is purified by column chromatography (silica gel, 5percent /hexane) affording 2,4-dichloro-6-methyl-pyrimidine-5-carboxylic acid methyl ester (0.45 g, 2.04 mmol, 59percent).

Reference: [1] Patent: US2011/152273, 2011, A1, . Location in patent: Page/Page column 28
[2] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 24, p. 5947 - 5950
[3] Patent: WO2015/131080, 2015, A1, . Location in patent: Paragraph 00270; 00274
[4] Patent: US2014/148454, 2014, A1, . Location in patent: Paragraph 0676
[5] Patent: WO2014/82739, 2014, A1, . Location in patent: Page/Page column 59
[6] Patent: WO2005/110416, 2005, A2, . Location in patent: Page/Page column 72-73
  • 2
  • [ 14205-39-1 ]
  • [ 36745-93-4 ]
Reference: [1] Patent: US2014/148454, 2014, A1,
[2] Patent: WO2014/82739, 2014, A1,
[3] Patent: WO2015/131080, 2015, A1,
[4] Patent: WO2005/110416, 2005, A2,
  • 3
  • [ 936020-16-5 ]
  • [ 36745-93-4 ]
Reference: [1] Patent: US2014/148454, 2014, A1,
[2] Patent: WO2014/82739, 2014, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 36745-93-4 ]

Chlorides

Chemical Structure| 3177-20-6

[ 3177-20-6 ]

Methyl 2,4-dichloropyrimidine-5-carboxylate

Similarity: 0.87

Chemical Structure| 51940-64-8

[ 51940-64-8 ]

Ethyl 2,4-Dichloro-5-pyrimidinecarboxylate

Similarity: 0.85

Chemical Structure| 41103-17-7

[ 41103-17-7 ]

Ethyl 4-chloropyrimidine-5-carboxylate

Similarity: 0.77

Chemical Structure| 2134-36-3

[ 2134-36-3 ]

Ethyl 4-chloro-2-methylpyrimidine-5-carboxylate

Similarity: 0.76

Chemical Structure| 108381-23-3

[ 108381-23-3 ]

Ethyl 2-chloro-4,6-dimethylpyrimidine-5-carboxylate

Similarity: 0.74

Esters

Chemical Structure| 3177-20-6

[ 3177-20-6 ]

Methyl 2,4-dichloropyrimidine-5-carboxylate

Similarity: 0.87

Chemical Structure| 51940-64-8

[ 51940-64-8 ]

Ethyl 2,4-Dichloro-5-pyrimidinecarboxylate

Similarity: 0.85

Chemical Structure| 41103-17-7

[ 41103-17-7 ]

Ethyl 4-chloropyrimidine-5-carboxylate

Similarity: 0.77

Chemical Structure| 2134-36-3

[ 2134-36-3 ]

Ethyl 4-chloro-2-methylpyrimidine-5-carboxylate

Similarity: 0.76

Chemical Structure| 108381-23-3

[ 108381-23-3 ]

Ethyl 2-chloro-4,6-dimethylpyrimidine-5-carboxylate

Similarity: 0.74

Related Parent Nucleus of
[ 36745-93-4 ]

Pyrimidines

Chemical Structure| 3177-20-6

[ 3177-20-6 ]

Methyl 2,4-dichloropyrimidine-5-carboxylate

Similarity: 0.87

Chemical Structure| 51940-64-8

[ 51940-64-8 ]

Ethyl 2,4-Dichloro-5-pyrimidinecarboxylate

Similarity: 0.85

Chemical Structure| 41103-17-7

[ 41103-17-7 ]

Ethyl 4-chloropyrimidine-5-carboxylate

Similarity: 0.77

Chemical Structure| 2134-36-3

[ 2134-36-3 ]

Ethyl 4-chloro-2-methylpyrimidine-5-carboxylate

Similarity: 0.76

Chemical Structure| 108381-23-3

[ 108381-23-3 ]

Ethyl 2-chloro-4,6-dimethylpyrimidine-5-carboxylate

Similarity: 0.74